HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Haruhiko Kamada Selected Research

Silicon Dioxide (Silica)

6/2015Cutaneous exposure to agglomerates of silica nanoparticles and allergen results in IgE-biased immune response and increased sensitivity to anaphylaxis in mice.
10/2012Amorphous silica nanoparticles enhance cross-presentation in murine dendritic cells.
2/2012Amorphous silica nanoparticles size-dependently aggravate atopic dermatitis-like skin lesions following an intradermal injection.
5/2011Silica and titanium dioxide nanoparticles cause pregnancy complications in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Haruhiko Kamada Research Topics

Disease

25Neoplasms (Cancer)
01/2020 - 06/2003
7Breast Neoplasms (Breast Cancer)
01/2015 - 09/2007
6Inflammation (Inflammations)
01/2016 - 03/2004
5Infections
10/2021 - 07/2009
4Autoimmune Diseases (Autoimmune Disease)
10/2020 - 08/2009
4Rheumatoid Arthritis
10/2020 - 01/2008
3COVID-19
11/2021 - 10/2021
3Neoplasm Metastasis (Metastasis)
07/2015 - 09/2007
3Necrosis
08/2009 - 03/2004
2Acute Lung Injury
11/2021 - 10/2021
2Lung Injury
11/2021 - 05/2004
2Hypersensitivity (Allergy)
01/2016 - 06/2015
2Lung Neoplasms (Lung Cancer)
07/2015 - 02/2011
2Atopic Dermatitis (Atopic Eczema)
06/2015 - 02/2012
2Triple Negative Breast Neoplasms
01/2015 - 09/2014
2Virus Diseases (Viral Diseases)
01/2010 - 12/2009
2Hepatitis
11/2008 - 01/2008
2Asthma (Bronchial Asthma)
05/2004 - 03/2004
2Acute Kidney Injury (Acute Renal Failure)
03/2004 - 04/2003
1Diabetic Nephropathies (Diabetic Nephropathy)
01/2022
1Chronic Renal Insufficiency
01/2022
1Cardiovascular Diseases (Cardiovascular Disease)
11/2021
1Pneumonia (Pneumonitis)
10/2021
1Reinfection
10/2021
1Body Weight (Weight, Body)
10/2021
1Contact Dermatitis (Eczema, Contact)
01/2021
1Experimental Arthritis
10/2020
1Arthritis (Polyarthritis)
10/2020
1Graft vs Host Disease (Graft-Versus-Host Disease)
01/2020
1Hypoxia (Hypoxemia)
01/2016
1Obesity
09/2015
1Anaphylaxis (Anaphylactic Shock)
06/2015
1Colonic Neoplasms (Colon Cancer)
07/2014
1Prostatic Neoplasms (Prostate Cancer)
07/2014
1Lymphatic Metastasis
12/2013
1Amyloid Plaque
02/2013
1Alzheimer Disease (Alzheimer's Disease)
02/2013
1Immune System Diseases (Immune Disorders)
10/2012
1Malignant Mesothelioma
04/2012

Drug/Important Bio-Agent (IBA)

14Proteins (Proteins, Gene)FDA Link
01/2022 - 02/2009
11Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2020 - 03/2004
10Type I Tumor Necrosis Factor ReceptorsIBA
10/2020 - 01/2008
9CytokinesIBA
10/2021 - 03/2004
6Type II Tumor Necrosis Factor ReceptorsIBA
10/2020 - 03/2009
6antineoplaston A10 (A 10)IBA
01/2015 - 01/2011
5Biological ProductsIBA
01/2016 - 02/2004
4Silicon Dioxide (Silica)FDA LinkGeneric
06/2015 - 05/2011
4EphA1 Receptor (Eph Receptor)IBA
01/2015 - 01/2011
3Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2011
3VaccinesIBA
10/2021 - 01/2010
3ChemokinesIBA
10/2021 - 01/2012
3AntibodiesIBA
01/2020 - 01/2010
3Pharmaceutical PreparationsIBA
01/2016 - 07/2014
3ProteomeIBA
07/2015 - 02/2011
3Monoclonal AntibodiesIBA
09/2014 - 01/2010
3Protein CIBA
09/2007 - 02/2004
2Immunoglobulin G (IgG)IBA
01/2021 - 06/2015
2Immunoglobulin E (IgE)IBA
06/2015 - 03/2004
2AntigensIBA
01/2015 - 10/2012
2EphrinsIBA
01/2015 - 09/2014
2Messenger RNA (mRNA)IBA
07/2014 - 12/2013
2Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
01/2012 - 12/2009
2Therapeutic UsesIBA
01/2011 - 11/2008
2Peptides (Polypeptides)IBA
07/2009 - 11/2007
2AnticoagulantsIBA
09/2007 - 02/2004
2Protein C InhibitorIBA
09/2007 - 02/2004
2Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
09/2007 - 02/2004
2poly(vinylpyrrolidone-co-dimethyl maleic anhydride)IBA
05/2006 - 04/2003
2Drug CarriersIBA
05/2006 - 04/2004
2Antineoplastic Agents (Antineoplastics)IBA
12/2004 - 03/2004
2OvalbuminIBA
05/2004 - 03/2004
1Blood Glucose (Blood Sugar)IBA
01/2022
1EnzymesIBA
11/2021
1AcidsIBA
11/2021
1CarboxypeptidasesIBA
11/2021
1Angiotensin IIIBA
11/2021
1Angiotensin-Converting Enzyme 2IBA
11/2021
1Viral RNAIBA
10/2021
1Viral AntigensIBA
10/2021
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
10/2021
1GlypicansIBA
01/2020
1Chimeric Antigen ReceptorsIBA
01/2020
1Neutralizing AntibodiesIBA
01/2018
1Capsid Proteins (Capsid Protein)IBA
01/2018
1furospinosulin-1IBA
01/2016
1IonsIBA
01/2016
1LipopolysaccharidesIBA
01/2016
1SilverIBA
01/2016
1MetalsIBA
01/2016
1lens epithelium-derived growth factorIBA
01/2016
1LipidsIBA
09/2015
1Glucose (Dextrose)FDA LinkGeneric
09/2015
1LuteolinIBA
09/2015
1oxysterol binding proteinIBA
07/2015
1AllergensIBA
06/2015
1Complementary DNA (cDNA)IBA
12/2013
1DNA (Deoxyribonucleic Acid)IBA
12/2013
1Amyloid (Amyloid Fibrils)IBA
02/2013

Therapy/Procedure

10Therapeutics
10/2021 - 04/2004
4Drug Therapy (Chemotherapy)
07/2009 - 03/2004